Cuban Swine Fever Vaccine Will Shortly Be Marketed
Developed by the Center for Genetic Engineering and Biotechnology in the eastern province of Camagüey, Porvac, commercial name of the vaccine, will have an effectiveness above 90 percent in the control and eradication of CSF, researchers said.


